VKH
BLCM

Virtu KCG Holdings’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Virtu KCG Holdings’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$728K Buy
+6,229
New +$773K 0.02% 819
2017
Q1 		– Sell
-1,489
Closed -$203K – 3909
2016
Q4 		$203K Buy
+1,489
New +$264K 0.01% 2580

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Virtu KCG Holdings's BLCM Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2017: 6,229 shares worth $728K. The stake represents 0.02% of the portfolio and ranks #819 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in BLCM as recently as Q4 2016.

Virtu KCG Holdings first reported a position in BLCM in Q4 2016 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold BLCM as of Q2 2017.

  • Virtu KCG Holdings held 6,229 shares of Bellicum Pharmaceuticals, Inc. worth $728K as of Q2 2017.
  • Bellicum Pharmaceuticals, Inc. was a new Virtu KCG Holdings position in Q2 2017.
  • Bellicum Pharmaceuticals, Inc. made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #819 holding.
  • Virtu KCG Holdings first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2016 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.